期刊文献+

川芎嗪与噻氯匹啶联合治疗缺血性脑血管病的临床研究 被引量:3

Clinical Comparison in Treating Ischemic vascular Disease with Ligustrazine and Ticlopidine
在线阅读 下载PDF
导出
摘要 目的 观察川芎嗪与噻氯匹啶联合治疗缺血性脑血管病的临床疗效。方法 本组 76例病人随机分为 3组 ,川芎嗪加噻氯匹啶 32例为治疗组 ;对照组 1 :单用噻氯匹啶 2 0例 ;对照组 2 :单用川芎嗪 2 4例。 1个月为 1个疗程。结果 治疗组总有效率为 96 .85 % ,优于对照组 1及对照组 2 (70 % ,87.5 % ) ;1年后复发率 9% ,对照组分别为 1 3.6 %和 1 1 .3%。结论 川芎嗪加噻氯匹啶治疗缺血性脑血管病优于单用川芎嗪或噻氯匹啶的疗效。 Objective To observe the effect of ligustrazine and ticlopidine on treating ischemic vascular disease (IVD). Methods 76 cases ( male 42 and female 34) of IVD patient were divided into 3 groups. Treatment group (32 cases) was treated with ligustrazine and ticlopidine. Control Ⅰ group (20 case) was treated with ticlopidine and control Ⅱ group (24 cases ) was treated with ligustrazine. The period of treated was 1 month. Results The total efficacy rate was 96.85% in treatment group, which was better than control Ⅰ group 70% and control Ⅱ group 87.5%. The recurrence rate in treatment group was 9% in control Ⅰ group(13.6%) and control Ⅱ group (11.3%) after 1 year follow-up. Conclusion Treating IVD with ligustrazine and ticlopidine might be better than with ticlopidine or ligustrazine alone.
作者 吴毓玲
出处 《黑龙江医学》 2004年第8期578-579,共2页 Heilongjiang Medical Journal
关键词 内科学 川芎嗪 噻氯匹啶 缺血性脑血管病 Ligustrazine Ticlopidine Ischemic vascular disease
  • 相关文献

参考文献4

二级参考文献3

共引文献93

同被引文献31

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部